merakris_logo_4color copy.jpg
Merakris Therapeutics to Release Final Part 1 Data From Phase 2 Multicenter Investigational Drug Study for Dermacyte® Liquid
20 févr. 2024 06h15 HE | Merakris Therapeutics
Merakris to present encouraging Phase 2 clinical drug trial data at annual Treasure Hunt Podiatry and Wound Conference in Los Angeles, CA, February 24-25.
merakris_logo_4color copy.jpg
Merakris To Share Data from Fully Enrolled First Part of Two-Part Dermacyte® Liquid Clinical Trial
05 déc. 2023 06h30 HE | Merakris Therapeutics
Merakris Therapeutics announces it has fully enrolled the first part of a clinical trial to evaluate its investigational drug product, Dermacyte® Liquid.
Logo.png
Chronic Venous Insufficiency Pipeline: Therapeutic Assessment, Emerging Drugs, Novel Devices, Key Pharma Players, Clinical Trials, and Growth Prospects Analysis | DelveInsight
02 nov. 2021 20h00 HE | DelveInsight Business Research LLP
Las Vegas, USA, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Chronic Venous Insufficiency Pipeline: Therapeutic Assessment, Emerging Drugs, Novel Devices, Key Pharma Players, Clinical Trials, and Growth...